1. Market Research
  2. > Biotechnology Market Trends
  3. > Biological Therapy

Biological Therapy Industry: Top Market Reports

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
2 votes

Global Biological Therapy Industry

The world biologics industry was worth almost $150 billion in 2010, according to research from BCC Research. The market is expected to record yearly growth of around 10% to reach almost $240 billion by 2015.

Market growth is fuelled by interest in biosimilars, the need to elaborate a superior drug pipeline, a move toward cost-reducing manufacturing technologies and appealing targets against challenging diseases.

Key Market Segments

The global gene therapy market is benefiting from increasing interest in the development of disease treatment. RNCOS notes that this market holds strong development potential as progress in the field of gene therapy facilitates research into the pathogenesis of diseases. This involves a move from research laboratories to clinical trials, which leads to greater potential for the biotechnology sector. Gene therapy market expansion is expected to be very strong over the coming years, fuelled by interest from biopharma companies focused on the area. Companies are expected to elaborate therapies for disease through on-site research and grow acquired therapies into commercial forms.

Gene therapy will prove vital to the medical industry to provide a disease-specific approach to developing treatments. The therapeutic applications of gene therapy are expanding to encompass areas like acquired diseases, including immunodeficiency syndromes. Growth is strong in the US, the EU, China, Japan and Canada. Cancer treatment is expected to represent the fastest-growing segment, followed by infectious diseases such as AIDS.

The global RNA Interference (RNAi) industry is expected to record 28% yearly growth for the five-year period ending 2015, reports RNCOS. Market growth will be fuelled by greater use of the expertise for functional genomics research, necessary for target validation, drug discovery and drug development. 

The worldwide market for cancer therapiesis expected to reach $225 billion by 2017, according to research from Global Industry Analysts. Market expansion will be fuelled by increasing numbers of cancer patients, adoption of new drugs and growing existing drugs. Market growth will also be driven by greater adoption of high-priced biologic therapies in cancer treatment. Medical treatment of cancer includes therapies such as chemotherapy, radiotherapy and gene therapy. The majority of cancer therapies are elaborated using hormones and cytokines, colony stimulating factors, monoclonal antibodies oncolytic viruses, cancer vaccines, antisense oligonucleotides and other approaches.

Leading companies in the sector include Takeda Pharmaceutical Company, GlaxoSmithKline, Eli Lilly, Amgen, Hoffmann-La Roche, Janssen Biotech, Sanofi-Aventis, AstraZeneca, Celgene Corporation, Novartis, Genentech and Bristol-Myers Squibb.

Regional Market Share

The US stem cell market is expected to record yearly growth of 45% between 2011 and 2013, reports RNCOS. The market has recorded strong growth over the past few years with massive investment despite the economic recession. Stem cell technologies and products are giving rise to breakthroughs in the treatment of diseases.

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+1 646 893 5945

32 Reports
Supply, Company Financials, Company
18 Statistics
Company, Finance, Company Financials
7 Reports
Company, Company Financials, Product Initiative
6 Statistics
Market Size, Demand, Company
5 Reports
Company, Company Financials, Supply
2 Statistics
Finance, Company Financials, Market Size
12 Reports
Supply, Company, Forecast
11 Statistics
Company, Market Size, Finance
16 Reports
Company, Supply, Forecast
41 Statistics
Market Size, Company, Market
110 Reports
Company Financials, Company, Supply
87 Statistics
Market Size, Company, Supply
18 Reports
Company, Company Financials, Product Initiative
34 Statistics
Market Size, Company, Supply
25 Reports
Company Financials, Company, Supply
9 Statistics
Finance, Company Financials, Company
31 Reports
Supply, Company, Company Operations
54 Statistics
Market Size, Supply, Company
4 Reports
Market Size, Supply, Company Financials
4 Statistics
Finance, Company Financials, Supply
Search in Biological Therapy Industry (About 1400 reports)
Parent industry: Biotechnology
Related industries: Biomaterial, Biopharmaceutical, Genetically Modified Organism, Genomics

About 900 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 220 - $ 10995)

Thawing System Market by Type, Sample, End User - Global Forecast to 2022

Thawing System Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

The global thawing system market projected to grow at a CAGR of 12.6% during the forecast period.The thawing system market is expected to reach USD 252.7 million by 2022 from USD 139.6 million in 2017, ...

3D Cell Culture Market: Global Forecast until 2022 $ 5650 November 2017

Radiotherapy Market: Global Forecasts until 2022 $ 5650 June 2017

Single-cell Analysis Market: Global Forecasts until 202 ... $ 5650 June 2017

Stem Cell Therapy Market: Global Forecasts until 2021 $ 5650 February 2017

Top 10 Bioprocess Technology: Forecast until 2021 $ 5650 January 2017

Cell Sorting Market: Forecasts until 2021 $ 5650 January 2017

Cartilage Repair/ Cartilage Regeneration Market: Foreca ... $ 5650 December 2016

PEGylated Proteins Market: Global Forecast until 2021 $ 5650 November 2016

Biopreservation Sector: Worldwide Forecast until 2021 $ 3500 July 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.